Safety study of a new drug in healthy volunteers
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a new investigational drug, called HRS-8797, in healthy people to see how safe it is and how the body processes it. It's an early-phase trial, so you may not directly benefit, but your participation can help find new treatments for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You need to be in good overall health, with no major medical problems.
- Your body mass index (BMI) must be between 18 and 28 (a healthy range).
- You must agree to use effective birth control during the study and for 4 weeks after the last dose, and not donate sperm or eggs.
- You must not have participated in any other drug trial in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new drug called HXN5003 in healthy volunteers to find the safest dose and see how the body handles it. It's an early-stage study, so the main goal is safety, not treating a disease.
This early-stage trial tests a new experimental medicine called REGN20423 in two groups: healthy volunteers and people with atopic dermatitis (a chronic skin condition causing itching and inflammation). The trial aims to assess whether the medicine is safe and well-tolerated.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This trial tests an experimental drug called HRS-3095 in healthy people to check its safety and how the body handles it. It may help find the right dose for future studies.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This trial tests an investigational drug called TRB-061 in healthy adults and people with atopic dermatitis (eczema). It aims to see if the drug is safe and how the body processes it. If you have moderate to severe eczema that started at least a year ago, you may be able to join the patient part of the study.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.